Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tri-APBI: Single-Institution Phase I/II Prospective Clinical Trial of 3-Fraction Accelerated Partial Breast Irradiation for Stage 0-I Breast Cancer.

Practical radiation oncology·2026
Same author

Adaptive radiotherapy incident-informed team training: a development and feasibility study.

Technical innovations & patient support in radiation oncology·2026
Same author

Development and feasibility of provider implementation tools for anti-inflammatory reliever therapy in community asthma practices.

Respiratory medicine·2026
Same author

The Role of MR Guided Radiation Therapy in Pancreatic Cancer Treatment.

Seminars in radiation oncology·2025
Same author

Long-Term Outcomes of Multimodality Accelerated Partial Breast Irradiation for Ductal Carcinoma In Situ.

Advances in radiation oncology·2025
Same author

Feasibility of Stereotactic Body Radiation Therapy for Pancreatic Tumors Abutting Organs at Risk Using Magnetic Resonance Guided Adaptive Radiation Therapy.

International journal of radiation oncology, biology, physics·2025

Related Experiment Video

Updated: Jun 11, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.1K

Complex Multi-site Stereotactic Body Re-irradiation With CT-Guided Online Adaptive Radiotherapy.

Domenic Sievert1, Alden D'Souza1, Xiaodong Zhao1

  • 1Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, USA.

Cureus
|October 4, 2024
PubMed
Summary
This summary is machine-generated.

Online adaptive radiotherapy successfully re-irradiated multiple metastatic lesions in a complex case. This advanced technique ensured optimal target coverage while protecting critical organs at risk, demonstrating its value in challenging re-treatment scenarios.

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Oncology

Background:

  • Online adaptive radiotherapy optimizes treatment plans based on daily anatomy to manage inter-fraction motion.
Keywords:
cbctethoshepatocellular carcinomahypersightsbrt

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.7K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.2K

Related Experiment Videos

Last Updated: Jun 11, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.1K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.7K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.2K
  • Daily delineation of targets and organs at risk (OARs) improves treatment outcomes, particularly in abdominal regions.
  • Adaptive radiotherapy is crucial for precise dose control during re-irradiation of OARs.